ALNYLAM PHARMACEUTICALS Stock Quote

$107.81 arrow  Change: 0.86 %Chge: 0.80% Vol: 43,389
End Of Day Prices
High: 107.91 | Low: 106 | Open: 106.13 | Close: 107.81
52 Wk High: 153.41 | 52 Wk Low: 70.97 | Todays Pivot: 107.24
Sector: add stock to watch list

ALNY Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY) Shareholder Perceptive Advisors LLC Decreased Its Position by $5.95 Million

Investors sentiment decreased to 1.4 in 2018 Q1. Its down 0.63, from 2.03 in 2017Q4. It is negative, as 25 investors sold ALNY shares while 67 reduced holdings. 43 funds opened positions while 86 raised stakes. 89.26 million shares or 1.02% less from 90.18 ...


Perceptive Advisors LLC Has Trimmed Its Stake in Alnylam Pharmaceuticals (ALNY) by $5.95 Million as Market Value Declined

Investors sentiment decreased to 1.4 in 2018 Q1. Its down 0.63, from 2.03 in 2017Q4. It dropped, as 25 investors sold ALNY shares while 67 reduced holdings. 43 funds opened positions while 86 raised stakes. 89.26 million shares or 1.02% less from 90.18 ...


After Reaching Milestone, Is Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)’s Short Interest Revealing Something?

Investors sentiment decreased to 1.4 in 2018 Q1. Its down 0.63, from 2.03 in 2017Q4. It turned negative, as 25 investors sold Alnylam Pharmaceuticals, Inc. shares while 67 reduced holdings. 43 funds opened positions while 86 raised stakes. 89.26 million ...


Why Is Alnylam (ALNY) Up 12.6% Since Its Last Earnings Report?

A month has gone by since the last earnings report for Alnylam Pharmaceuticals, Inc. (ALNY - Free Report) . Shares have added about 12.6% in that time frame. Will the recent positive trend continue leading up to its next earnings release, or is ALNY due ...


Alnylam Pharma (ALNY) Reports Updated Results from Phase 1/2 Study of Lumasiran in Patients with PH1

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today new positive results from its ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Alnylam Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ALNY to choose from. Visit here to build your stock quote widget »